The sale places an implied enterprise value of about £6.1-billion on the hospital group with legs in southern Africa, the United Arab Emirates and Switzerland.
Once the deal is finalised, Mediclinic will be owned 50/50 by diversified investment holding company Remgro and SAS, a subsidiary of global shipping company MSC . However, for the sale to take effect, it has to be approved by at least 75% of the shareholders, excluding Remgro, which already owns 328 million shares.
The takeover is expected to take effect in the first quarter of next year, after which Mediclinic will be delisted from the London Stock Exchange, the JSE and the Namibian Stock Exchange.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: